ExsoMed Passes Milestone Case with INnate Intramedullary Threaded Nail

ExsoMed’s INnate intramedullary threaded nail has been used in the treatment of 10,000 metacarpal fractures. This is an increase from 5,000 cases, achieved in 2020.

INnate is available in a variety of lengths, with a dual crest height design for an optimal fit within the intramedullary canal. INnate is the only non-compression option, constructed to avoid shortening of oblique and comminuted fractures, while providing simple fracture stabilization in minutes. The instrumentation is sterile-packed and single-use.

“10,000 successful INnate cases is a major achievement for ExsoMed. It further validates our approach in designing and developing innovative products and technologies for hand surgery,” said James Young Kim, ExsoMed’s Chief Marketing Officer. “For too long, innovation has been neglected in the hand surgery space, with subpar outcomes deemed acceptable for arguably the most vital human appendages. ExsoMed is here to change that. We believe our solutions will raise the standard of care in hand surgery by providing surgeons with user-friendly surgical tools that reduce the global cost of care and get patients back to work and daily activities faster.”